CINECA IRIS Institutional Research Information System

TUCCORI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.273
EU - Europa 1.706
AS - Asia 1.096
AF - Africa 200
SA - Sud America 40
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.204
IT - Italia 568
CN - Cina 487
SE - Svezia 373
SG - Singapore 221
GB - Regno Unito 193
BG - Bulgaria 156
DE - Germania 150
CI - Costa d'Avorio 107
IN - India 97
TR - Turchia 89
VN - Vietnam 74
FI - Finlandia 67
CA - Canada 57
SN - Senegal 46
NG - Nigeria 41
RU - Federazione Russa 35
HK - Hong Kong 34
FR - Francia 33
UA - Ucraina 29
AU - Australia 25
JP - Giappone 25
BR - Brasile 23
BE - Belgio 22
ID - Indonesia 18
KR - Corea 14
IR - Iran 12
CO - Colombia 11
MX - Messico 11
ES - Italia 10
NL - Olanda 10
PT - Portogallo 10
AT - Austria 9
CH - Svizzera 8
PL - Polonia 7
LT - Lituania 6
CL - Cile 5
MY - Malesia 5
TW - Taiwan 5
IE - Irlanda 4
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
PH - Filippine 3
PK - Pakistan 3
RO - Romania 3
BJ - Benin 2
EE - Estonia 2
IL - Israele 2
JO - Giordania 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
IM - Isola di Man 1
IQ - Iraq 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 6.344
Salva come PNG Salva come JPEG
Città #
Santa Clara 403
Chandler 312
Ann Arbor 255
Woodbridge 240
Fairfield 225
Shanghai 220
Ashburn 215
Houston 157
Sofia 156
Singapore 144
New York 110
Abidjan 107
Boardman 100
Florence 100
Wilmington 96
Serra 93
London 86
Milan 85
Seattle 80
Princeton 77
Cambridge 73
Lawrence 66
Medford 57
Beijing 52
Istanbul 49
Dakar 46
Ottawa 43
Lagos 41
Izmir 36
Helsinki 34
Dong Ket 32
Jacksonville 32
Hong Kong 30
Redwood City 29
Rome 29
Bremen 28
Kent 24
Pisa 24
Washington 24
Los Angeles 23
Nanjing 22
Brussels 20
Lancaster 20
Mumbai 20
Des Moines 19
Massa 18
San Diego 17
Fuzhou 16
Hyderabad 16
Munich 15
Ogden 14
Frankfurt am Main 13
Chicago 12
Dearborn 12
Ho Chi Minh City 12
Jakarta 12
Dallas 11
Marseille 10
Mountain View 10
Nanchang 10
Norwalk 10
Livorno 9
Modugno 9
Rio de Janeiro 9
Toronto 9
Falls Church 7
San Francisco 7
Tokyo 7
Warsaw 7
Jeju City 6
Lappeenranta 6
Melbourne 6
Quanzhou 6
Sydney 6
Tianjin 6
Turin 6
Wuhan 6
Bengaluru 5
Duncan 5
Jüchen 5
Kunming 5
Naples 5
New Malden 5
Phoenix 5
Redmond 5
Santiago 5
Santiago de Cali 5
Torres Vedras 5
Xiamen 5
Bern 4
Birmingham 4
Boulder 4
Cascina 4
Changsha 4
Chennai 4
Esslingen am Neckar 4
Guangzhou 4
Hefei 4
Jinan 4
Madrid 4
Totale 4.558
Salva come PNG Salva come JPEG
Nome #
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 203
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 157
Gabapentin-induced severe myopathy: a case report 156
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 149
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 139
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 132
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 131
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy 127
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 124
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 122
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 121
Role of A2a adenosine in the regulation of colonic motility in normal human colon 120
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 120
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 116
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope 116
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 107
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 99
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 98
Acute severe myopathy following single intravenous infusion of omeprazole 97
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 97
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 97
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab 96
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports 95
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat 93
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? 91
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 90
IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project 87
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 86
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 86
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 85
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 84
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 83
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study 82
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 81
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature 79
SSRIs and birth defects: Can a new statistical approach resolve old controversies? 79
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 78
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 73
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 73
Statin-associated psychiatric adverse events: a case/non case evaluation of an Italian database of spontaneous adverse drug reaction reporting 73
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 73
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 73
A clinician network for sharing patients experiences in pharmacovigilance: the PHARMACOWIKILANCE project 72
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 68
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 67
Potential and Actual Drug-Drug Interactions in Elderly Patients Admitted to an Emergency Department: Data from the ANCESTRAL-ED Study 66
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study 66
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 66
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease 65
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 65
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes? 64
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 64
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 64
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 63
Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study 63
Bleeding Related to Oral Anticoagulant Drugs as Cause of Emergency Department Admission: Analysis of Data from the Tuscan MEREAFaPS Network 61
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 61
Characterization of the Risk of Bleeding with Novel Oral Anticoagulants and Warfarin: A Pilot Case-Control Study 60
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 59
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 58
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 56
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 55
Update of Certolizumab Pegol Safety Profile: A Systematic Review and Meta-Analysis 55
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 54
Haemorrhagic gastritis and bleeding following rofecoxib administration 52
Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian National Network of Pharmacovigilance database 49
Estimation of Theoretical Cost Preventability Achievable with an Effective Pharmacovigilance Activity in a Pharmacovigilance Regional Centre in Italy 49
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks 43
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 42
Severe Cardiac Events Following Treatment with Trastuzumab in Women with Breast Cancer: A Meta-Analysis of Clinical Trials and Cohort Studies 42
Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases 40
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 34
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 32
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 30
A regulatory overview of biosimilars across selected countries 28
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 28
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 26
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 26
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 25
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 23
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 22
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 22
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 21
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 19
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 18
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 18
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 16
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 15
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience 14
Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments 14
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 11
Communicating Drug Safety 11
Authors’ response: Inhibiting IL-6 in COVID-19: we are not sure that sgp130(fc) can affect only the trans-signaling receptor pathway of IL-6 9
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 5
Totale 6.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 0 66 55 56 27 42 23
2020/2021366 17 15 11 9 36 9 16 32 25 22 19 155
2021/2022960 17 42 86 88 156 134 37 45 54 23 66 212
2022/20231.324 177 225 87 98 116 126 33 73 271 2 110 6
2023/20241.039 64 65 85 35 124 176 98 56 42 50 117 127
2024/20251.347 38 126 113 245 272 405 148 0 0 0 0 0
Totale 6.524